ARCHIVES

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Budget Presents “Themes,” Not Individual NIH Institutes.

April 13, 2001

Program Project Payline Is 125; Budget Cuts Will Allow NCI To Fund 49 Competing P01s

February 28, 1992

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

February 11, 1994

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

Firm To Collaborate With R. W. Johnson On Vaccines.

December 1, 2000